Representative before the EPO

Employment test 201 - 500 employees
Company dna murgitroyd and company
operating since 1975
Headquarter in Glasgow and 17 offices
active in Legal Services, IP Consulting, Matchmaking and Trading, and IP Portfolio Processing

Malcolm Charles Main has worked on the following 59 EPO patent applications which have been published in the last five years:

EP11779004

INHIBITORS OF PI3K-DELTA AND METHODS OF THEIR USE AND MANUFACTURE

IPC classification:
A61K 31/47, A61K 31/4709, A61K 31/497, A61K 31/52, A61K 31/5377, A61K 31/551, A61P 35/00, C07D 215/06, C07D 241/44, C07D 401/14, C07D 405/12, C07D 413/14, C07D 473/34, C07D 495/04
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION IN PROGRESS
EP11731617

COMBINATIONS OF KINASE INHIBITORS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/498, A61K 31/517, A61K 31/63, A61K 31/7088, A61K 39/395, A61K 45/06, A61P 35/00
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Applicant:
Vanderbilt University
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
PATENT GRANTED
EP11801506

SINGLE-WALLED CARBON NANOTUBE/SIRNA COMPLEXES AND METHODS RELATED THERETO

IPC classification:
A61K 9/48, A61K 31/7105, A61K 38/17, A61K 38/18, A61K 47/48, A61P 35/00
Agent:
Multiple attorneys, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP11784368

ANTIGEN SPECIFIC TREGS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS

IPC classification:
A61K 35/12, A61K 39/00, C12N 5/0783
Applicant:
California Institute of Technology
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION IN PROGRESS
EP12720743

METHOD OF TREATING LYMPHOMA USING PYRIDOPYRIMIDINONE INHIBITORS OF PI3K/MTOR

IPC classification:
A61K 31/00, A61K 31/519, A61P 35/02
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12725560

INHIBITORS OF INDUCIBLE FORM OF 6-PHOSPHOFRUCTOSE-2-KINASE

IPC classification:
A61K 31/506, A61P 35/00, C07D 239/42, C07D 401/04, C07D 403/04, C07D 403/12, C07D 405/04, C07D 405/12, C07D 405/14, C07D 409/04, C07D 413/04, C07D 417/04, C07D 417/14
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12766542

PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/4196, A61K 31/498, A61K 31/519, A61P 35/00
Applicant:
Sanofi, S.A.
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12831223

BIOMARKERS RELATED TO INSULIN RESISTANCE AND METHODS USING THE SAME

IPC classification:
A23D 9/00, C12Q 1/00
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION IN PROGRESS
EP12795915

N-(3-{[(3-{[2-CHLORO-5-(METHOXY)PHENYL]AMINO}QUINOXALIN-2-YL)AMINO]SULFONYL}PHENYL)-2-METHYLALANINAMIDE AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR FOR THE TREATMENT OF LYMPHOPROLIFERATIVE MALIGNANCIES

IPC classification:
A61K 31/498, A61P 35/02
Applicant:
Sanofi, S.A.
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP12731817

COMBINATION THERAPIES FOR TREATING HEMATOLOGIC MALIGNANCIES USING PYRIDOPYRIMIDINONE INHIBITORS OF PI3K/MTOR WITH BENDAMUSTINE AND/OR RITUXIMAB

IPC classification:
A61K 31/4184, A61K 31/519, A61K 39/395, A61P 35/00, A61P 35/02
Applicant:
Sanofi, S.A.
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11764895

PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS

IPC classification:
A61K 31/4985, A61P 35/00, C07D 217/22, C07D 237/34, C07D 403/10, C07D 405/04, C07D 409/04, C07D 417/10, C07D 471/04
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13744099

METHOD FOR DETECTING POLYOMAVIRUS REACTIVATION

IPC classification:
G01N 33/53, G01N 33/567
Applicant:
Temple University of the Commonwealth System of Higher Education
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION IN PROGRESS
EP14157698

Biomarkers related to metabolic age and methods using the same

IPC classification:
C07H 21/02, C07H 21/04, C12Q 1/68, G01N 33/50
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12782510

DIAGNOSIS AND TREATMENT OF COPD

IPC classification:
G01N 33/577, G01N 33/68
Applicant:
Temple University of the Commonwealth System of Higher Education
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION IN PROGRESS
EP11790718

BENZOXAZEPINES AS INHIBITORS OF MTOR AND METHODS OF THEIR USE AND MANUFACTURE

IPC classification:
A61K 31/437, C07D 513/04
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11805679

BENZOXAZEPINES AS INHIBITORS OF P13K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE

IPC classification:
A61K 31/553, A61K 35/00, C07D 413/04, C07D 413/14, C07D 417/14, C07D 471/04, C07D 513/14
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13765159

CO-PRECIPITATION METHOD

IPC classification:
A61L 24/04, A61L 27/52
Agent:
Multiple attorneys, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP13770310

ANTI-EMP2 THERAPY REDUCES CANCER STEM CELLS

IPC classification:
A61K 39/395, C07K 16/00
Applicant:
The Regents of the University of California
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP13772822

SUBCUTANEOUS ELECTRODES FOR CRANIAL NERVE STIMULATION

IPC classification:
A61N 1/05, A61N 1/36
Applicant:
The Regents of the University of California
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP11793623

BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE

IPC classification:
A61K 31/423, C07D 413/14
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11791722

BENZOXAZEPINES AS INHIBITORS OF P13K/mTOR AND METHODS OF THEIR USE AND MANUFACTURE

IPC classification:
A61K 31/5377, A61P 35/00, C07D 413/04, C07D 413/14, C07D 471/04
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13777937

COMPOSITIONS AND METHODS FOR IDENTIFYING AND DIAGNOSING SALT SENSITIVITY OF BLOOD PRESSURE

IPC classification:
C12N 15/11, C12Q 1/68, G01N 33/50
Applicant:
University of Virginia Patent Foundation
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION IN PROGRESS
EP13807463

TRANSDERMAL HORMONE REPLACEMENT THERAPIES

IPC classification:
A61K 31/56
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP13807188

SOLUBLE ESTRADIOL CAPSULE FOR VAGINAL INSERTION

IPC classification:
A01N 45/00
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP13806855

NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES

IPC classification:
A01N 45/00
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP13807121

PROGESTERONE FORMULATIONS

IPC classification:
A61K 9/48, A61K 31/57
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP13807833

COMPOSITIONS AND METHODS FOR REGULATING GLUCOSE HOMEOSTASIS AND INSULIN ACTION

IPC classification:
A61K 31/495, C07D 498/04
Applicant:
University of Virginia Patent Foundation
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP13739245

PREDICTING RESISTANCE TO DISEASE

IPC classification:
C12Q 1/68
Agent:
Multiple attorneys, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14743690

ENGINEERED PHYSICAL ALIGNMENT OF STEM CELL-DERIVED CARDIOMYOCYTES

IPC classification:
C12N 5/00, C12N 5/02
Applicant:
University of California, Irvine
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14745477

AGONIST FUSION PROTEIN FOR CD40 OX40 AND USES THEREOF

IPC classification:
C07K 19/00
Applicant:
Thomas Jefferson University
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14746893

PD-L1 AND PD-L2-BASED FUSION PROTEINS AND USES THEREOF

IPC classification:
A61K 39/00
Applicant:
Thomas Jefferson University
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14746017

BIOMARKERS RELATED TO INSULIN RESISTANCE PROGRESSION AND METHODS USING THE SAME

IPC classification:
C12Q 1/54
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14745909

SYSTEM AND METHOD FOR MODELING BRAIN DYNAMICS IN NORMAL AND DISEASED STATES

IPC classification:
A61B 5/0476, A61B 5/055
Applicant:
The Regents of the University of California
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14757085

METHODS AND COMPOSITIONS FOR TARGETING RNA POLYMERASES AND NON-CODING RNA BIOGENESIS TO SPECIFIC LOCI

IPC classification:
A01H 5/00, C12N 15/29, C12N 15/82
Applicant:
The Regents of the University of California
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14757627

AMPHIPHILIC DERIVATIVES OF THIOETHER CONTAINING BLOCK COPOLYPEPTIDES

IPC classification:
C07K 1/02, C07K 1/107, C07K 5/12
Applicant:
The Regents of the University of California
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14753541

THIN FILM VASCULAR STENT FOR ARTERIAL DISEASE

IPC classification:
A61F 2/06, A61F 2/82
Applicant:
The Regents of the University of California
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14769471

PLURALITY OF LAMINATION FOR SOFT TISSUE COMPRESSION SUPPORT, PROTECTION AND BRACING INTELLIGENT TEXTILE FOR EQUINE AND EQUESTRIAN SPORTS OR ACTIVITIES

IPC classification:
A61D 9/00
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14773841

ENTEROCOCCUS FAECALIS BACTERIOPHAGE AND USES THEREOF

IPC classification:
A01N 63/00, C12N 7/00
Applicant:
Temple University of the Commonwealth System of Higher Education
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14778729

THIN LUMINAIRE

IPC classification:
F21S 2/00, F21V 5/00
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14795204

PROBIOTIC PREVENTION AND TREATMENT OF COLON CANCER

IPC classification:
A61K 39/02, C07H 13/00, G01N 33/00
Applicant:
California Institute of Technology
Agent:
Multiple attorneys, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14820357

SHIP INHIBITION TO COMBAT OBESITY

IPC classification:
A61K 31/56, A61K 31/565, A61P 3/00, A61P 3/04
Applicant:
The Research Foundation for the State University of New York - Suny Upstate Medical University
Agent:
Multiple attorneys, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14842802

LIVER X RECEPTOR (LXR) MODULATORS

IPC classification:
C07D 401/04, C07D 409/14
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14841483

LIVER X RECEPTOR (LXR) MODULATORS

IPC classification:
C07D 401/04, C07D 409/14
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP14862905

VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITONS AND METHODS

IPC classification:
A61F 6/06, A61K 9/00, A61K 31/565
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14860949

COMPOSITIONS AND METHODS FOR TREATING MELANOMA

IPC classification:
A61K 38/21, A61P 37/04
Applicant:
University of Virginia Patent Foundation
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14861719

DEVICE, SYSTEM AND METHOD FOR REDUCING HEADACHE PAIN

IPC classification:
A61H 23/02, A61M 21/02
Applicant:
The Regents of the University of California
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP14863895

IMMERSIVE COMPACT DISPLAY GLASSES

IPC classification:
H04N 13/00, H04N 13/04
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP11776614

9H-PURINE COMPOUNDS AS PI3K-DELTA INHIBITORS AND METHODS FOR THEIR MANUFACTURE

IPC classification:
A61K 31/52, A61P 29/00, A61P 35/00, C07D 473/34
Applicant:
Exelixis Inc
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
PATENT GRANTED
EP14870759

BIOMARKERS OF DE NOVO LIPOGENESIS AND METHODS USING THE SAME

IPC classification:
A61K 35/60, A61P 35/04, G01N 33/50
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP15700265

PREDICTING RESISTANCE TO VIRAL INFECTION

IPC classification:
C12Q 1/68
Agent:
Multiple attorneys, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP15768772

PROGESTERONE FORMULATIONS

IPC classification:
A61K 9/48, A61K 31/57, A61K 47/30
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP15779439

AN AIR CONDITIONING METHOD USING A STAGED PROCESS USING A LIQUID DESICCANT

IPC classification:
F24F 3/14, F24F 11/00
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP16190952

SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS

IPC classification:
A61K 31/223, A61P 35/00, C07C 235/38, C07C 271/44, C07C 311/27, C07C 317/18, C07C 317/28, C07C 323/41, C07C 323/49, C07C 323/65, C07D 213/02, C07D 295/088, C07D 295/15, C07D 295/155, C07F 7/18
Applicant:
Temple University of the Commonwealth System of Higher Education
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION PUBLISHED
EP15727528

NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES

IPC classification:
A61K 9/00, A61K 31/565, A61K 31/57, A61P 5/30, A61P 5/34
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP15729908

PREDICTING THE ABILITY OF ATLANTIC SALMON TO UTILISE DIETARY PIGMENT BASED ON THE DETERMINATION OF POLYMORPHISMS

IPC classification:
C12Q 1/68
Agent:
Malcolm Charles Main, Murgitroyd & Company
Agent:
HGF Limited
Status:
EXAMINATION REQUESTED
EP15734543

METHODS AND COMPOSITIONS USING ONE-SIDED TRANSPOSITION

IPC classification:
C12N 9/10, C12N 15/10, C12Q 1/68
Applicant:
Illumina, Inc.
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
EXAMINATION REQUESTED
EP17154259

METHODS AND COMPOSITIONS FOR TARGETING RNA POLYMERASES AND NON-CODING RNA BIOGENESIS TO SPECIFIC LOCI

IPC classification:
A01H 5/00, C07K 14/415, C12N 15/29, C12N 15/82
Applicant:
The Regents of the University of California
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
APPLICATION PUBLISHED
EP15842246

METHODS AND SYSTEMS FOR ANALYZING NUCLEIC ACID SEQUENCING DATA

IPC classification:
C12Q 1/68
Applicant:
Illumina, Inc.
Agent:
Malcolm Charles Main, Murgitroyd & Company
Status:
Request for examination was made
EP15822334

COMBINATION OF A PD-1 ANTAGONIST AND A LISTERIA-BASED VACCINE FOR TREATING PROSTATE CANCER

IPC classification:
A61K 35/74, A61K 39/02, A61K 39/12, A61P 35/00
Applicant:
Merck Sharp & Dohme Corporation
Agent:
Malcolm Charles Main, Murgitroyd & Company
Agent:
Schwarz & Partner
Status:
Request for examination was made

Please Sign in to use this feature